1-2-dioleoyloxy-3-(trimethylammonium)propane and Carcinoma--Small-Cell

1-2-dioleoyloxy-3-(trimethylammonium)propane has been researched along with Carcinoma--Small-Cell* in 2 studies

Other Studies

2 other study(ies) available for 1-2-dioleoyloxy-3-(trimethylammonium)propane and Carcinoma--Small-Cell

ArticleYear
In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection.
    International journal of nanomedicine, 2010, Aug-09, Volume: 5

    DOTAP/cholesterol-based lipoplexes are successfully used for delivery of plasmid DNA in vivo especially to the lungs, although low systemic stability and circulation have been reported. To achieve the aim of discovering the best method for systemic delivery of DNA to disseminated tumors we evaluated the potential of formulating DOTAP/cholesterol lipoplexes with a polyethylene glycol (PEG)-modified lipid, giving the benefit of the shielding and stabilizing properties of PEG in the bloodstream.. A direct comparison of properties in vitro and in vivo of 4 different DOTAP/cholesterol-based lipoplexes containing 0%, 2%, 4%, and 10% PEG was performed using reporter gene activity and radioactive tracer lipid markers to monitor biodistribution.. We found that 10% PEGylation of lipoplexes caused reduced retention in lung and heart tissues of nude mice compared to nonPEGylated lipoplexes, however no significant delivery to xenograft flank tumors was observed. Although PEGylated and nonPEGylated lipoplexes were delivered to cells the ability to mediate successful transfection is hampered upon PEGylation, presumably due to a changed uptake mechanism and intracellular processing.. The eminent in vivo transfection potency of DOTAP/cholesterol-based lipoplexes is well established for expression in lung tumors, but it is unsuitable for expression in non first pass organs such as xenograft flank tumors in mice even after addition of a PEG-lipid in the formulation.

    Topics: Animals; Carcinoma, Small Cell; Cell Line, Tumor; Cholesterol; Drug Delivery Systems; Fatty Acids, Monounsaturated; Gene Expression; Genes, Reporter; Genetic Therapy; Humans; In Vitro Techniques; Liposomes; Lung Neoplasms; Male; Mice; Mice, Nude; Nanomedicine; Polyethylene Glycols; Quaternary Ammonium Compounds; Transfection; Transplantation, Heterologous

2010
Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes).
    International journal of cancer, 1998, Aug-31, Volume: 77, Issue:5

    Antisense oligodeoxy-nucleoside phosphorothioates (OPTs) of L-myc were encapsulated into reconstituted influenza-virus-A envelopes (virosomes). The envelopes of the virosomes consisted of a single positively charged (cationic) lipid bilayer. Binding of cationic virosomes to cellular receptors that are membrane glycoproteins or glycolipids containing terminal sialic acid is mediated by the hemagglutinin glycoprotein (HA) of the influenza virus. After internalization through receptor-mediated endocytosis, cationic virosomes fuse efficiently with the membranes of the endosomal-cell compartment, and as a consequence the encapsulated OPT are delivered to the cell cytoplasma. Examination by fluorescence microscopy of the cellular uptake of cationic virosomes containing fluorescein-labeled OPT showed rapid and efficient incorporation of virosomes. Addition of cationic virosomes (75-150 microl) containing antisense L-myc OPT in the picomolar range to small-cell-lung-cancer (SCLC) cell cultures that expressed highly the L-myc oncogene led to strong inhibition of thymidine incorporation in a concentration-dependent manner. Virosome-entrapped sense L-myc OPT and random-order OPT had only minimal effects on the thymidine uptake. Cells of SCLC cell line NCI-H82 expressing a very low level of L-myc were not affected by antisense-L-myc virosomes. In Western-blot analysis, expression of L-myc protein was suppressed in the antisense-virosome-treated NCI-H209 cells but not in untreated control NCI-H209 cells. These results suggest that cationic virosomes may have great potential as an efficient delivery system for antisense oligonucleotides in cancer therapy.

    Topics: Antibodies, Monoclonal; Carcinoma, Small Cell; Cell Division; Endocytosis; Fatty Acids, Monounsaturated; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Influenza A virus; Liposomes; Lung Neoplasms; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-myc; Quaternary Ammonium Compounds; Transfection; Tumor Cells, Cultured

1998